Disrupting well-established markets, such as healthcare, often requires pioneering for innovative technologies. That is exactly what Echosens has done with FibroScan®, its flagship liver health product. Developed from the PHD research of founder Laurent Sandrin, Echosens non-invasive diagnostics and monitoring technology has radically improved and simplified the diagnosis of liver health. But how is a successful start-up leveraging its growth beyond its revolutionary flagship product? For new CEO Sven Henrichwark, the key has been taking a fresh look at why the firm has flourished, and what made it great in the first place.